Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a center within the Administration for Strategic Preparedness and Response [1] (ASPR) located within the U.S. Department of Health and Human Services (HHS) responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear ...
This funding from BARDA will assist us in determining whether we can bring a transformational, next-generation approach to global vaccination,” said Steven Lo, Vaxart’s Chief Executive Officer.
The Biomedical Advanced Research and Development Authority (BARDA) has issued an $8.6 million contract to OraSure Technologies Inc (NASDAQ: OSUR) for developing a 2nd generation Ebola test on the ...
Operation Warp Speed used BARDA as the financial interface between the U.S. federal government and the biomedical industry. [21] The program was initially being funded with $10 billion, [1] with additional funds allocated through BARDA. [1] Funding was increased to about $18 billion by October 2020. [22]
Biomedical Advanced Research and Development Authority (BARDA) Advanced Research Projects Agency for Health (ARPA-H) Department of Homeland Security
“We are delighted our continued collaboration with BARDA is advancing Ebanga™ development toward supplying treatment and ensuring communities are prepared against Ebola,” said Simon Lowry, M.D., chief medical officer, head of research and development, Emergent. “Ebola is a devastating infectious illness with limited treatment options.
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the Department of Health and Human Services. [1] Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that ...
U.S. District Judge Loren AliKhan ordered the Trump administration not to halt grant funding until at least Feb. 3, when another hearing will be held on the dispute.